Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2025-12-26 @ 12:35 AM
Study NCT ID:
NCT04416594
Status:
COMPLETED
Last Update Posted:
2020-06-05
First Post:
2020-05-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Acquired FXIII Deficiency on Morbidity and Mortality
Sponsor:
Patricia Duque González
Organization:
Study Overview
Official Title:
Impact of Acquired FXIII Deficiency on Morbidity and Mortality Among Hospitalized Patients
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Observational prospective study aiming to assess acquired FXIII deficiency implications in morbidity and mortality
Detailed Description:
All patients admitted to a large tertiary hospital with FXIII levels below 70% during their hospital stay are assessed. Data regarding patient background, blood transfusion, morbidity and mortality is registered.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: